Understanding the Impact of Tariffs on Clinical Trials Recent headlines about proposed US tariffs on European countries highlight the volatility of the global trade environment. As reported this week in Fierce Pharma , potential new duties on several European nations raise questions about the future of US–EU trade relations. This uncertainty can significantly impact the pharmaceutical industry. For sponsors running global clinical trials, this kind of uncertainty translates i

Client Overview A global biopharmaceutical company approached CSI to support a Phase III oncology study requiring Opdivo (nivolumab) as a comparator. The study spanned 4 countries across North America, Europe and Asia-Pacific, with a target enrolment of over 500 patients. The client’s main objective was to ensure timely delivery of branded Opdivo for multiple trial sites while maintaining transparent, full chain of custody and documentation.   Challenge There were several key